These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37932795)

  • 1. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
    van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
    Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of Electronic Nose Technology in Sarcoidosis.
    van der Sar IG; Moor CC; Oppenheimer JC; Luijendijk ML; van Daele PLA; Maitland-van der Zee AH; Brinkman P; Wijsenbeek MS
    Chest; 2022 Mar; 161(3):738-747. PubMed ID: 34756945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.
    Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease.
    Moor CC; Oppenheimer JC; Nakshbandi G; Aerts JGJV; Brinkman P; Maitland-van der Zee AH; Wijsenbeek MS
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32732331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
    de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
    Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis.
    de Vries R; Brinkman P; van der Schee MP; Fens N; Dijkers E; Bootsma SK; de Jongh FH; Sterk PJ
    J Breath Res; 2015 Oct; 9(4):046001. PubMed ID: 26469298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
    Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
    Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath.
    de Vries R; Muller M; van der Noort V; Theelen WSME; Schouten RD; Hummelink K; Muller SH; Wolf-Lansdorf M; Dagelet JWF; Monkhorst K; Maitland-van der Zee AH; Baas P; Sterk PJ; van den Heuvel MM
    Ann Oncol; 2019 Oct; 30(10):1660-1666. PubMed ID: 31529107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.
    de Vries R; Dagelet YWF; Spoor P; Snoey E; Jak PMC; Brinkman P; Dijkers E; Bootsma SK; Elskamp F; de Jongh FHC; Haarman EG; In 't Veen JCCM; Maitland-van der Zee AH; Sterk PJ
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
    Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
    Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
    Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
    Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank.
    Krauss E; Haberer J; Maurer O; Barreto G; Drakopanagiotakis F; Degen M; Seeger W; Guenther A
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31623141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopy.
    Abdel-Aziz MI; Brinkman P; Vijverberg SJH; Neerincx AH; de Vries R; Dagelet YWF; Riley JH; Hashimoto S; Montuschi P; Chung KF; Djukanovic R; Fleming LJ; Murray CS; Frey U; Bush A; Singer F; Hedlin G; Roberts G; Dahlén SE; Adcock IM; Fowler SJ; Knipping K; Sterk PJ; Kraneveld AD; Maitland-van der Zee AH; ;
    J Allergy Clin Immunol; 2020 Nov; 146(5):1045-1055. PubMed ID: 32531371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled Breath Profiles Before, During and After Exacerbation of COPD: A Prospective Follow-Up Study.
    van Velzen P; Brinkman P; Knobel HH; van den Berg JWK; Jonkers RE; Loijmans RJ; Prins JM; Sterk PJ
    COPD; 2019 Dec; 16(5-6):330-337. PubMed ID: 31588813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
    Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
    Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosis.
    Licht JC; Seidl E; Slingers G; Waters V; de Vries R; Post M; Ratjen F; Grasemann H
    J Cyst Fibros; 2023 Sep; 22(5):888-893. PubMed ID: 36849333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaled breath analysis in interstitial lung disease.
    van der Sar IG; Wijsenbeek MS; Moor CC
    Curr Opin Pulm Med; 2023 Sep; 29(5):443-450. PubMed ID: 37405699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations.
    van Bragt JJMH; Principe S; Hashimoto S; Versteeg DN; Brinkman P; Vijverberg SJH; Weersink EJM; Scichilone N; Maitland-van der Zee AH
    Metabolites; 2021 Dec; 11(12):. PubMed ID: 34940630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.